Jazz Pharmaceuticals (JAZZ)

Company Ticker Sector | Industry Quality PAR
Jazz Pharmaceuticals JAZZ Healthcare | Biotechnology 94 15.1%
Current Price (07/17) $135.93
CAPS Rating (Rate this stock on CAPS) Foolcaps 4
Expected Income Statement
Current Sales 2,000.7
Sales Growth Forecast 13.2%
Net Profit Margin 45.8%
Projected Shares Outstanding 62.01
EPS - Five year Forecast $27.43
Average P/E Ratio 10.0
Projected Average Price $274.32
Price Appreciation (Annualized) 15.1%
Annual Dividend Yield 0.0%
Projected Annual Return 15.1%
Quality
Financial Strength 86 21.6
EPS Stability 94 23.6
Industry Sales Growth Rate 16.5% 10.0
Industry Net Profit Margin 29.0% 19.7
Calculated Quality Rating 74.9
Fool CAPS

Total Players

308 Outperforms
67 Underperforms
 

All-Stars (69)

54 Outperforms (78%)
15 Underperforms
 
Fundamental Data Updated: 06/28/2019

MIPAR 8.8%  
Sweet Spot 13.8% - 18.8%  

Top In Biotechnology

Ticker Quality PAR
JAZZ 94 15.1%
BIIB 79 15.7%
BSTC 80 15.3%
REGN 80 22.7%
RGEN 71 15.8%

Top In Healthcare

Ticker Quality PAR
ALGN 99 21.4%
ABMD 82 19.1%
JAZZ 94 15.1%
CMD 92 14.1%
ABBV 87 15.4%